Institutional investors hold a majority ownership of ISIS through the 89.03% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2013, these large investors purchased a net $308.2 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NPC OF AMERICA Bought 5.4 Thousand shares of Isis Pharmaceuticals Inc